间歇性暴怒障碍的精神、神经与躯体共病
这项队列研究从TriNetX研究网络匹配了30357例间歇性暴怒障碍(IED)患者与30357例对照,分析其精神、神经与躯体共病。IED患者中95.7%有另一种精神科诊断,所有精神科亚类及92%的精神科诊断与IED显著相关,神经与躯体疾病也呈广泛关联。作者强调需整合心理与躯体健康的诊疗路径。
要点
- IED患者中95.7%(29054例)有另一种精神科诊断,所有精神科亚类均与IED显著相关。
- 成人人格与行为障碍(除IED)HR 76.6(95%CI 65.4-89.6),物质使用障碍HR 2.1(95%CI 2.0-2.2)。
- 神经退行性疾病HR 5.0(95%CI 4.1-6.1)、癫痫HR 4.9(95%CI 4.3-5.6)与IED关联较强。
核心结论
- IED与精神、神经及躯体疾病存在广泛共病,作者强调需采取同时关注心理与躯体健康的整合诊断与治疗路径。
研究设计与样本
- 这项队列研究从TriNetX研究网络(日期为2024年1月31日)识别匹配的IED患者组与无IED对照组,分析电子病历数据,首次至末次已知就诊的平均(SD)时间为4.8(5.4)年。
主要发现
- 共纳入30357例IED患者与30357例人口学匹配对照,每组21313例(70%)为男性,首次就诊平均(SD)年龄26(17)岁。
- IED患者中95.7%(29054例)有另一种精神科诊断,所有精神科亚类及92%的精神科诊断与IED显著相关。
- 精神科诊断的HR从物质使用障碍的2.1(95%CI 2.0-2.2)到成人人格与行为障碍(除IED)的76.6(95%CI 65.4-89.6)。
- 神经系统疾病中神经退行性疾病HR 5.0(95%CI 4.1-6.1)、癫痫HR 4.9(95%CI 4.3-5.6)最高,其次为运动障碍HR 3.1(95%CI 2.8-3.5)、脑性瘫痪HR 2.6(95%CI 2.2-3.0)、睡眠障碍HR 2.2(95%CI 2.1-2.3)。
- 躯体疾病中肥胖HR 1.6(95%CI 1.5-1.7)、高脂血症HR 1.5(95%CI 1.4-1.5)、高血压HR 1.6(95%CI 1.5-1.7)、胃食管反流病HR 1.7(95%CI 1.7-1.9)与IED显著相关。
关键数值与推荐
- IED诊断仅占总患者人群的0.03%。
- IED患者中95.7%(29054例)有另一种精神科诊断,所有精神科亚类及92%的精神科诊断与IED显著相关。
- 成人人格与行为障碍(除IED)HR 76.6(95%CI 65.4-89.6),物质使用障碍HR 2.1(95%CI 2.0-2.2)。
- 神经退行性疾病HR 5.0(95%CI 4.1-6.1),癫痫HR 4.9(95%CI 4.3-5.6),运动障碍HR 3.1(95%CI 2.8-3.5),脑性瘫痪HR 2.6(95%CI 2.2-3.0),睡眠障碍HR 2.2(95%CI 2.1-2.3)。
- 肥胖HR 1.6(95%CI 1.5-1.7),高脂血症HR 1.5(95%CI 1.4-1.5),高血压HR 1.6(95%CI 1.5-1.7),胃食管反流病HR 1.7(95%CI 1.7-1.9)。
临床怎么用
- 作者认为这些发现强调需采取整合诊断与治疗路径,同时关注IED患者的心理与躯体健康方面。
局限性
- 局限性涉及对医疗记录的依赖及IED诊断率低,警示这些发现的普遍性。
- 作者强调需在前瞻性研究中进一步验证,并对精神障碍患者中IED进行更准确、更包容的诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Intermittent explosive disorder (IED) is an understudied psychiatric condition marked by impulsive aggression and poorly regulated emotional control, often resulting in interpersonal and societal consequences. Better understanding of comorbidities can improve screening, diagnosis, and treatment. OBJECTIVE: To investigate the prevalence of IED and its associations with psychiatric, neurological, and somatic disorders. DESIGN, SETTING, AND PARTICIPANTS: In this cohort study, matched groups of patients with and without IED were identified from the TriNetX Research Network (dated January 31, 2024). Electronic medical record data were analyzed. The mean (SD) time from the first to last known visits was 4.8 (5.4) years. EXPOSURE: Lifetime diagnosis of IED. MAIN OUTCOMES AND MEASURES: Main outcomes were International Statistical Classification of Diseases, Tenth Revision, Clinical Modification diagnostic categories and root codes. Cox proportional hazard models were used to estimate and compare probabilities of acquiring other diagnoses. Key measures include the numbers and proportions of patients with these diagnoses and adjusted hazard ratios (HRs) for IED. RESULTS: Overall, 30 357 individuals with IED and 30 357 demographically matched controls were included. In each group, 21 313 (70%) were male, with a mean (SD) age at the first visit 26 (17) years. Despite only 0.03% of the total patient population having an IED diagnosis, extensive comorbidities with psychiatric, neurological, and somatic conditions were found. A notable 95.7% of individuals with IED (29 054 individuals) had another psychiatric diagnosis. All psychiatric subcategories and 92% of the psychiatric diagnoses were significantly associated with IED, with HRs ranging from 2.1 (95% CI, 2.0-2.2) for substance use disorder to 76.6 (95% CI, 65.4-89.6) for disorders of adult personality and behavior (excluding IED). Among neurological conditions, neurodegenerative diseases (HR, 5.0; 95% CI, 4.1-6.1) and epilepsy (HR, 4.9; 95% CI, 4.3-5.6) had the highest HRs, followed by movement disorders (HR, 3.1; 95% CI, 2.8-3.5), cerebral palsy (HR, 2.6; 95% CI, 2.2-3.0), and sleep disorders (HR, 2.2; 95% CI, 2.1-2.3). Significant associations with IED were also observed for many somatic diseases, including obesity (HR, 1.6; 95% CI, 1.5-1.7), hyperlipidemia (HR, 1.5; 95% CI, 1.4-1.5), hypertension (HR, 1.6; 95% CI, 1.5-1.7), and gastroesophageal reflux disease (HR, 1.7; 95% CI, 1.7-1.9). CONCLUSION AND RELEVANCE: These findings highlight the extensive comorbidities between IED and psychiatric, neurological, and somatic disorders, emphasizing the need for integrated diagnostic and treatment approaches addressing both psychological and physical health aspects of IED. Limitations related to reliance on medical records and low diagnostic rates of IED caution the generalizability of these findings, underscoring the need for further validation in prospective studies and more accurate, inclusive diagnosis of IED in patients with mental disorders.
引用
- Zhang-James Y, Paliakkara J, Schaeffer J, et al. Psychiatric, Neurological, and Somatic Comorbidities in Intermittent Explosive Disorder. JAMA Psychiatry. 2025. PMID: 39841469. doi:10.1001/jamapsychiatry.2024.4465
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。